Clinical Expertise to Fuel Your Study
As a CRO specialized in early clinical development, we offer clinical trial services, overnight observation capabilities at our Phase 1 clinical site, and regulatory support. We utilize a collaborative approach which centers on taking your product to the next stage of development. WCCT is focused in these key areas:
Tobacco, Nicotine, and Smoking
With state-of-the-art smoking facilities and in-house scientific and regulatory expertise, WCCT helps Sponsors fulfill PMTA requirements and supports the development of tobacco, nicotine, and electronic nicotine device systems (ENDS) product review applications.
Infectious Disease and Vaccines
Since our founding in 1998, WCCT has conducted over 80 studies in the area of Infections and Infectious Disease. Supported by expert scientific, medical, regulatory, and clinical staff, the WCCT clinical pharmacology unit supports the streamlined clinical development of new vaccines, delivery systems, treatments and antimicrobial agents in a timely, cost-effective manner. Partner with a leader that has a track record in infectious diseases.
Due to our extensive early clinical development experience and emphasis on overnight confinement, WCCT delivers a comprehensive new level of data collection to early phase ophthalmology studies. Additionally, WCCT’s vast site network allows Sponsors to move seamlessly from Phase 1 to Phase 2.
Strategically Delivered Clinical Services
WCCT is committed to serving as an end-to-end solution for early clinical development. Therefore, we have geared all of our personnel, processes, partnerships, and vendors to suit the specific needs of early phase clinical trials:
- Regulatory expertise for complex and specialty trial designs
- Project Managers with extensive background in Phase 1 trials
- Safety Reference Laboratory with 24/7 availability
- Dedicated Recruitment Department with proven retention programs